Erol AB works with sales and marketing of pharmaceuticals.
Since its inception in January 2000, Erol AB has been manufacturing a drug - Niferex®, oral treatment for iron deficiency. Niferex is manufactured in Germany since the late 1970s and was launched in Sweden in 2000. In a number of countries, Niferex is the market leader in oral iron drugs. The product is called Ferro Sanol Duodenal in the following countries: Algeria, Iran, Lebanon, Egypt, Turkey, Germany and Finland as Obsidan® and Niferex in Norway and Denmark. Since May 2006 there are also Niferex oral drops.
ADDRESS
Medeon Science Park
SE-205 12 Malmö
CONTACT
David Erlich
Phone: +46 (0)70 8540835
Website: http://www.niferex.se/
MEDEON IS AN IMPORTANT LIFE SCIENCE NODE WITH ITS CENTRAL LOCATION AND SPECIFIC NETWORKS, OFFERING ONE OF THE ÖRESUND REGION'S BEST GROWTH ENVIRONMENTS FOR COMPANIES. MEDEON PROMOTES INTERCHANGE BETWEEN THE ACADEMIC WORLD, PUBLIC SECTOR AND INDUSTRY.
Catrine Pauckstadt
Communications Manager